[1]
Cocchi G., Mastrocola M., Capelli M. et al.: Immunological patterns in
young children with Down syndrome: is there a temporal trend? Acta
Paediatr 2007; 96: 1479–1482.
[2]
Kusters M.A., Verstegen R.H., Gemen E.F., et al.: Intrinsic defect of the
immune system in children with Down syndrome: a review.Clin Exp
Immunol 2009; 156: 189–93.
[3]
Dion N., Kishnani P.S., Zimmerman S.: Clinical manifestations of
hematologic and oncologic disorders in patients with Down syndrome.
Am J Med Genet C Semin Med Genet. 2006; 142C: 149–157.
[4]
Elsayed S.M., Elsayed G.M.: Phenotype of apoptotic lymphocytes in
children with Down syndrome. Immun Ageing 2009; 6: 2.
[5]
Ram G., Chinen J.: Infections and immunodeficiency in Down syndrome.
Clin Exp Immunol 2011; 164: 9–16.
[6]
Bloemers B.L., van Bleek G.M., Kimpen J.L. et al.: Distinct abnormalities
in the innate immune system of children with Down syndrome. J Pediatr
2010; 156: 804.
[7]
Hilton J.M., Fitzgerald D.A., Cooper D.M.: Respiratory morbidity of
hospitalized children with Trisomy 21. J Paediatr Child Health 1999; 35:
383–386.
[8]
Nespoli L., Burgio G.R., Ugazio A.G. et al.: Immunological features of
Down’s syndrome: a review. J Intellect Disabil Res 1993; 37: 543–51.
[9]
Yang Q., Rasmussen S.A., Friedman J.M.: Mortality associated with
Down’s syndrome in the USA from 1983 to 1997: a population-based
study. Lancet 2002; 359: 1019–1025.
[10]
Ribeiro L.M., Jacob C.M., Pastorino A.C. et al.: Evaluation of factors
associated with recurrent and/or severe infections in patients with
Down’s syndrome. J Pediatr 2003; 79: 141–148.
[11]
Corsi M.M., Ponti W., Venditti A. et al.: Proapoptotic activated T-cells in
the blood of children with Down’s syndrome: relationship with dietary
antigens and intestinal alterations. Int J Tissue React 2003; 25: 117–
125.
[12]
Cetiner S., Demirhan O., Inal T.C. et al.: Analysis of peripheral blood T-cell
subsets, natural killer cells and serum levels of cytokines in children with
Down syndrome. Int J Immunogenet 2010; 37: 233–237.
Scholar Google
PubMed